Three weeks ago, a patient in her early fifties sat across from me holding a bag of products she'd been using for the past year. Two glycolic serums, a salicylic toner, a "resurfacing" mask she'd found through a skincare influencer, and a retinol she wasn't sure was doing anything. Her skin looked irritated. Not damaged, but overtreated at the surface and undertreated where it mattered.
"I've been doing chemical peels at home," she said, "but the lines are still there."
She wasn't wrong about the lines. She was wrong about what a consumer-grade acid can reach. And that confusion -- between surface brightening and actual structural resurfacing -- is the most common misunderstanding I see in patients who have done their research but not had the clinical conversation.
The spectrum is real, but the steps between levels are larger than people think
Chemical exfoliation exists on a continuum from cosmetic maintenance to controlled surgical injury. At one end, you have AHAs and BHAs sold in drugstores. At the other, phenol-croton oil peels that reach the reticular dermis and require cardiac monitoring. These are not different strengths of the same thing. They are fundamentally different procedures with different mechanisms, different targets, and different risk profiles.
Glycolic acid, the most commonly used AHA, works because it is a small molecule that penetrates the stratum corneum efficiently. At consumer concentrations (5-15%), it loosens intercellular bonds in the outermost skin layer, improving radiance and texture over repeated use. At professional concentrations (20-70%), it creates a more meaningful exfoliative response. Fischer et al. reviewed glycolic acid outcomes across concentrations in the Journal of Clinical and Aesthetic Dermatology (2010) and confirmed efficacy for melasma, mild acne scarring, and early photoaging, with a low adverse event profile below 50% concentration.
Salicylic acid, a BHA, is oil-soluble, which lets it penetrate into sebaceous follicles. That makes it useful for acne-prone skin and comedonal congestion, but its depth of penetration is inherently limited. It is a surface-level tool -- effective in its lane, but not a resurfacing agent.
The gap between these products and a clinic-based TCA peel is not a matter of degree. It is a change in target tissue.
When I reach for TCA instead of glycolic
Trichloroacetic acid at 25-35% concentration crosses the epidermis and reaches the upper dermis. That distinction matters because the structural changes patients care about -- etched fine lines, persistent dyschromia, textural irregularity from cumulative sun damage -- live in layers that glycolic acid cannot consistently reach.
Sitohang et al. conducted a systematic review of five prospective trials in Dermatology Research and Practice (2021) and found that 35% TCA significantly reduced wrinkling depth in photoaged skin. In a direct comparison, TCA produced greater melanin index reduction and wrinkle depth improvement than glycolic acid combination therapy.
I use TCA when a patient has tried a series of lighter peels and plateaued, or when the initial assessment shows damage that lives below the epidermal-dermal junction. One patient, a woman in her mid-forties with years of unprotected sun exposure from competitive sailing, had done six professional glycolic peels over eighteen months with modest improvement. A single 30% TCA peel produced more visible change in her perioral lines and malar dyschromia than the entire glycolic series. That is not a knock on glycolic acid. It is a recognition that the tool has to match the layer.
Khunger et al. demonstrated this quantitatively in the Indian Journal of Dermatology, Venereology and Leprology (2009): patients treated with 15% TCA for melasma saw their MASI scores drop from 9.25 to 4.52 -- a 51% reduction. The glycolic acid group showed a comparable 53% reduction, but from a higher baseline (18.42 to 8.67), and both groups required hydroquinone priming for optimal results. The practical takeaway: for pigmentary concerns, either can work when the protocol is built correctly, but TCA tends to produce results in fewer sessions.
The phenol conversation is a different conversation entirely
Phenol-croton oil peels occupy their own category. Hetter's landmark work in Aesthetic Surgery Journal (2000) changed how we understand these procedures by demonstrating that croton oil -- not phenol -- is the primary agent creating dermal change. The classic Baker-Gordon formula (3 mL phenol, 2 mL water, 8 drops liquid soap, 3 drops croton oil) penetrates 0.60-0.80 mm into the reticular dermis, triggering a reorganization of collagen fibers that produces wrinkle effacement visible at the histologic level.
Baker et al. confirmed this in a 2009 porcine model study, also in Aesthetic Surgery Journal: croton oil solutions produced a brisker inflammatory response than phenol alone, with histologic examination showing horizontally arranged parallel collagen bundles -- the structural change responsible for visible wrinkle reduction. This is a controlled injury, and the results reflect that.
I have performed phenol-croton peels on selected patients with severe perioral rhytids who were not candidates for or interested in a facelift. The results can be striking. But the selection criteria are narrow. The patient must understand weeks of recovery, the risk of permanent hypopigmentation, the need for cardiac monitoring during the procedure, and the reality that this is a surgical-grade intervention performed on the skin. Landau's 2025 retrospective of 102 female patients undergoing phenol-croton peels reported 92% patient satisfaction (rating 4 or 5 out of 5), which is high -- but satisfaction rates only tell part of the story when you are selecting patients carefully.
Skin of color requires a different calculus
This is where I part ways with protocols that treat all skin as interchangeable. Sarkar et al. published one of the most useful datasets on chemical peel safety in darker skin types in the Indian Journal of Dermatology (2009): across 473 superficial peels in Fitzpatrick III-VI patients, the overall complication rate was 3.8%, but Fitzpatrick VI patients had 5.14 times higher odds of adverse events (OR 5.14, 95% CI 1.21-21.8). Post-inflammatory hyperpigmentation occurred in 30% and erythema in 40% of Fitzpatrick VI patients specifically.
I've seen this play out clinically. A patient with Fitzpatrick V skin came to me after a medium-depth TCA peel performed at a medical spa left her with persistent hyperpigmentation across both cheeks that was worse than the melasma she had been trying to treat. The peel was applied without adequate priming, without a test spot, and without a follow-up plan for pigmentary complications. The provider was not a dermatologist or plastic surgeon.
For darker skin types, I almost always start with a sequential approach: 4-6 weeks of hydroquinone and retinoid priming, a test spot, and careful titration upward. A 2025 study in the Journal of Cosmetic Dermatology (PMID 40620441) validated this sequential approach, showing that carefully staged high-concentration glycolic acid followed by TCA in Fitzpatrick IV-V patients produced statistically significant MASI score improvement at 12 weeks without serious adverse events. The protocol worked because the sequence was deliberate.
Combination protocols: what the newer data supports
The most interesting development in the peel literature is not a new acid -- it is the combination of chemical peels with mechanical and biologic adjuncts. Wasiluk et al. published a controlled trial in the Journal of Clinical Medicine (2023) with 20 patients (ages 40-65) receiving eight weekly treatments: one side treated with chemical peels alone, the other with peels plus microneedling. The combination side showed superior improvements in hydration and elasticity, with decreased melanin and erythema indices on both sides and no significant adverse effects.
A 2025 meta-analysis in PMC confirmed these findings across a larger evidence base: chemical peeling combined with microneedling outperformed either modality alone for acne scars. The mechanism likely involves microneedling's creation of microchannels that enhance acid penetration, combined with the wound-healing cascade triggered by dual injury.
I have not adopted same-day peel-plus-needling protocols in my practice. In my experience, spacing the two treatments by at least 7-10 days gives each modality time to complete its inflammatory cycle without overwhelming the skin's repair capacity. For patients with darker skin types, Grimes presented data at the 2024 Pigmentary Disorders Exchange Symposium in Chicago supporting sequential (not simultaneous) protocols with pre-treatment tyrosinase inhibitors for Fitzpatrick IV-VI patients.
The question I actually want patients to ask
Patients tend to ask "which peel is best?" That is the wrong question. The right question is: what layer of my skin is the problem, and who has the training to treat that layer safely?
A glycolic peel is a maintenance tool. A TCA peel is a clinical intervention. A phenol-croton peel is a surgical procedure. They share a name -- "chemical peel" -- but they share almost nothing else. The complication risk, the recovery, the training required, and the results are categorically different.
The patient who started this conversation -- the one with the bag of products -- ended up getting a single 25% TCA peel after four weeks of skin preparation. At her six-week follow-up, the perioral lines that had survived a year of at-home acids were visibly softened. She kept the glycolic serum for maintenance. She stopped expecting it to do what it was never designed to do.
What is the actual complication rate for chemical peels by depth?
Superficial peels (glycolic, salicylic) carry a 1-3% complication rate, primarily mild erythema and transient peeling. Medium-depth TCA peels have a 5-8% complication rate, with post-inflammatory hyperpigmentation being the most common issue, particularly in darker skin types. Deep phenol-croton oil peels carry a 15-20% overall complication rate, including prolonged erythema and a 2-5% risk of permanent hypopigmentation, which is why patient selection and surgeon experience matter significantly.
How many glycolic acid treatments equal one TCA peel?
There is no exact equivalence because they target different tissue depths. Multiple glycolic acid treatments may approximate some of the cosmetic improvement of a single medium-depth TCA peel for surface-level concerns like mild dyschromia, but glycolic acid cannot consistently reach the upper dermis where etched lines and structural photoaging reside. In my clinical experience, patients who plateau after a series of glycolic peels often see meaningful additional improvement from a single well-planned TCA treatment.
Are chemical peels safe for darker skin types?
They can be, but the protocol must be adjusted. Sarkar et al. found that Fitzpatrick VI patients had 5.14 times higher odds of adverse events from superficial peels compared to lighter skin types. The key is adequate priming (4-6 weeks of hydroquinone and retinoid), test spots before full treatment, and careful concentration selection. A 2025 study confirmed that sequential glycolic-then-TCA protocols produce significant improvement in Fitzpatrick IV-V patients when the sequence is managed properly.
When should I choose a phenol peel over TCA?
Phenol-croton oil peels are reserved for patients with severe perioral or periorbital rhytids who want maximal wrinkle effacement and accept several weeks of recovery with possible permanent pigment changes. I consider them when TCA-depth intervention is unlikely to reach the reticular dermis changes driving the patient's concern, and when the patient's skin type, cardiac health, and recovery expectations align with the procedure's demands.